Govt sets target to open 25000 Jan Aushadhi Kendras by March 2027: Minister

The government has launched the scheme to make quality generic medicines available at affordable prices to all.;

Published On 2025-07-30 06:58 GMT   |   Update On 2025-07-30 06:58 GMT
Advertisement

New Delhi: A total of 16,912 Jan Aushadhi Kendras (JAKs) have been opened till 30.6.2025 under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme. This information was given by the Union Minister of State for Chemicals and Fertilizers Smt Anupriya Patel in Rajya Sabha in a written reply to a question.

2,110 medicines and 315 surgicals, medical consumables and devices are under the scheme product basket, covering all major therapeutic groups, such as cardiovascular, anti-cancers, anti-diabetic, anti-infectives, anti-allergic and gastro-intestinal medicines and nutraceuticals. Almost all generic medicines included in the National List of Essential Medicines, except lab reagents and vaccines, are included in the scheme product basket.

For smooth supply and product availability at JAKs, an end-to-end IT-enabled supply chain system has been established, comprising a central warehouse, four regional warehouses and 39 distributors appointed across the country. Availability of 400 fast-moving products is monitored regularly to ensure their availability. Further, a minimum stocking mandate has been implemented for 200 medicines consisting of the 100 top-selling medicines in the scheme product basket and 100 fast-selling medicines in the market. Under the stocking mandate, the JAK owners become eligible for claiming incentive based on stocks of the said 200 medicines maintained by them.

Advertisement

The government has launched the scheme to make quality generic medicines available at affordable prices to all. As a result of the scheme, in the last 11 years, estimated savings of about Rs 38,000 crore have accrued to citizens in comparison to the prices of branded medicines, contributing significantly to the sharp reduction in out-of-pocket expenditure by households from 62.6% of total health expenditure in financial year (FY) 2014-15 to 39.4% in FY2021-22 as per the National Health Accounts Estimates.

With a view to further expand reach to Janaushadhi medicine and thereby reduce out-of-pocket expenditure, the Government has set a target to open 25,000 Jan Aushadhi Kendras by March 2027. In opening of JAKs, the Government has adopted a franchisee-like model, in which online applications from individual entrepreneurs, non-governmental organisations, societies, trusts, firms, private companies, etc. are invited online through the website of the Pharmaceuticals and Medical Devices Bureau of India (www.janaushadhi.gov.in) from across the country, including in various blocks and tehsils.

State- and Union-territory-wise number of Jan Aushadhi Kendras (JAKs) opened are:

S. No.

State / Union territory

Total number of JAKs opened till 30.6.2025

1

Andaman and Nicobar Islands

9

2

Andhra Pradesh

281

3

Arunachal Pradesh

35

4

Assam

179

5

Bihar

900

6

Chandigarh

14

7

Chhattisgarh

316

8

Dadra and Nagar Haveli and Daman and Diu

40

9

Delhi

552

10

Goa

22

11

Gujarat

812

12

Haryana

465

13

Himachal Pradesh

75

14

Jammu and Kashmir

335

15

Jharkhand

163

16

Karnataka

1,480

17

Kerala

1,629

18

Ladakh

2

19

Lakshadweep

1

20

Madhya Pradesh

592

21

Maharashtra

723

22

Manipur

61

23

Meghalaya

26

24

Mizoram

15

25

Nagaland

22

26

Odisha

753

27

Puducherry

33

28

Punjab

520

29

Rajasthan

545

30

Sikkim

12

31

Tamil Nadu

1,432

32

Telangana

203

33

Tripura

31

34

Uttar Pradesh

3,550

35

Uttarakhand

331

36

West Bengal

753

Total

16,912


Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News